- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.07. | Aclarion, Inc.: Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK | 2 | GlobeNewswire (USA) | ||
| 26.06. | Aclarion, Inc.: Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK | 8 | GlobeNewswire (USA) | ||
| 26.06. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 25.06. | Aclarion, Inc.: Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London | 1 | GlobeNewswire (USA) | ||
| 18.06. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.05. | Aclarion, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 29.04. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 25.04. | Aclarion, Inc.: Aclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain | 3 | GlobeNewswire (USA) | ||
| 12.04. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 28.03. | Aclarion, Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
| 27.02. | Aclarion, Inc.: Aclarion Announces Closing of $3.0 Million Public Offering | 3 | GlobeNewswire (USA) | ||
| 26.02. | Aclarion stock tumbles 63% on pricing of $3M public offering | 3 | Seeking Alpha | ||
| 26.02. | Why Aclarion (ACON) Shares Are Down Over 60% Today | 2 | Benzinga.com | ||
| 26.02. | Aclarion, Inc.: Aclarion Announces Pricing of $3.0 Million Public Offering | 2 | GlobeNewswire (USA) | ||
| 26.02. | Why Is Aclarion (ACON) Stock Down 19% Today? | 3 | InvestorPlace | ||
| 21.02. | Aclarion, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 21.02. | Aclarion, Inc. - S-1/A, General form for registration of securities | 3 | SEC Filings | ||
| 05.02. | Aclarion, Inc.: Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership | 267 | GlobeNewswire (Europe) | Company is initiating its pivotal multicenter, prospective, randomized CLARITY trial to build on clinical evidence demonstrating superior surgical outcomes when Nociscan is utilized in surgical decisioning... ► Artikel lesen | |
| 31.01. | Aclarion, Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
| 29.01. | Why Is Aclarion (ACON) Stock Down 16% Today? | 1 | InvestorPlace |
Seite:
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EMEIS | 13,230 | +1,21 % | emeis: Growth in Revenue in First-Half 2024 at €2,772 Million (Up 9.2%) | Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240726471228/en/
emeis (Paris:EMEIS):
Growth in revenue in first-half... ► Artikel lesen | |
| NANO-X IMAGING | 8,590 | +9,29 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
| BUTTERFLY NETWORK | 1,065 | -2,29 % | Butterfly Network Reports First Quarter 2024 Financial Results | BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with handheld, whole-body ultrasound... ► Artikel lesen | |
| CARMAT | 2,600 | +0,58 % | CARMAT accelerates its sales momentum and reiterates its confidence in its development outlook | 20 implants of the Aeson artificial heart performed in the first half of 2024
Pace of 4 implants per month in the second quarter
Half-year sales at €3.2 million, higher than the... ► Artikel lesen | |
| GOODRX | 8,850 | +1,26 % | Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira | First biosimilar with an exclusive low cash price on the GoodRx platform RIDGEFIELD, Conn. and SANTA MONICA, Calif., July 18, 2024 /PRNewswire/ -- Boehringer Ingelheim and GoodRx (Nasdaq: GDRX),... ► Artikel lesen | |
| JOINT CORP | 14,220 | +4,33 % | The Joint Corp. to Host Conference Call on Thursday, August 8th to Discuss Second Quarter 2024 Results | ||
| HYPERFINE | 1,170 | +1,74 % | Hyperfine, Inc. - 8-K, Current Report | ||
| PROGYNY | 29,140 | +1,89 % | Progyny, Inc. Announces Details for Its Second Quarter 2024 Results Report | ||
| MIMEDX | 7,760 | +0,65 % | MiMedx Group, Inc: MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature - Scientific Reports | ||
| PROCEPT BIOROBOTICS | 61,85 | -3,96 % | Procept Biorobotics: Point72 Europe London LLP hat 123800 Aktien dazugekauft! | Medizintechnik-Unternehmen mit 58%-Halbjahresrallye bei Procept Biorobotics (PRCT) Immer noch rote Zahlen, aber viel Potenzial! Procept Biorobotics (PRCT) - ISIN US74276L1052 Rückblick: Das Medizintechnik-Unternehmen... ► Artikel lesen | |
| OUTSET MEDICAL | 3,740 | +0,81 % | Outset Medical Reports First Quarter 2024 Financial Results | SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) ("Outset" or the "Company"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity... ► Artikel lesen | |
| BIOMERICA | 0,351 | +0,40 % | Biomerica, Inc.: Biomerica Announces inFoods IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024 | With IBS affecting 10 to 15% of the global population, the associated $21 billion in direct medical costs and absenteeism underscores the urgent need of innovative solutions. Recognized as the 7th... ► Artikel lesen | |
| ATRICURE | 22,120 | -5,99 % | AtriCure (ATRC) Gains China Approval for AtriClip LAA System | ||
| ATRION | 420,00 | 0,00 % | Dividendenbekanntmachungen (14.06.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AARONS COMPANY INC US00258W1080 0,125 USD 0,1163 EUR ADAMS RESOURCES & ENERGY INC US0063513081 0,24 USD 0,2234 EUR AEGON LTD BMG0112X1056 - 0... ► Artikel lesen | |
| TALKSPACE | 2,035 | -2,16 % | Talkspace, Inc. (TALK): Hedge Funds Are Bullish On This NASDAQ Penny Stock Now |
Das Unternehmen ACLARION INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,014 (+4,58 %) liegt der Kurs bei 0,320 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ACLARION INC finden Sie auf Wallstreet Online.
